Goldman Sachs’s Imago BioSciences IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-541,009
Closed -$19.4M – 6499
2022
Q4
$19.4M Buy
541,009
+515,384
+2,011% +$12.9M ﹤0.01% 1990
2022
Q3
$385K Sell
25,625
-195,057
-88% -$3.16M ﹤0.01% 5147
2022
Q2
$2.96M Buy
220,682
+125,855
+133% +$2M ﹤0.01% 3692
2022
Q1
$1.83M Buy
94,827
+7,065
+8% +$147K ﹤0.01% 4336
2021
Q4
$2.08M Buy
+87,762
New +$2.03M ﹤0.01% 4209

Goldman Sachs's IMGO Position: Q1 2023 in Review

Goldman Sachs sold out of Imago BioSciences (IMGO) in Q1 2023, closing a stake of 541,009 shares — an estimated $19.4M sold.

Goldman Sachs first reported a position in IMGO in Q4 2021 and held it in 5 quarters. The position peaked at $19.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Goldman Sachs reported no remaining Imago BioSciences position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 541,009 Imago BioSciences shares in Q1 2023, an estimated $19.4M.
  • Goldman Sachs first reported a position in Imago BioSciences in Q4 2021 and held it in 5 quarters.
  • Goldman Sachs's Imago BioSciences position peaked at $19.4M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.